![Karl Birthistle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karl Birthistle worked as a Director of Clinical Development & Safety Assessments at Philip Morris International Management SA, Deputy Head of Division Clinical Review at Swissmedic, and Vice President of Clinical & Regulatory Affairs at Abivax SA.
| Unternehmen | Position | Ende |
|---|---|---|
| ABIVAX | General Counsel | 01.04.2017 |
Swissmedic
 Swissmedic Miscellaneous Commercial ServicesCommercial Services Operates as national authorization for drugs and medical devices, which ensures safe and effective medical products form human and animal health | Corporate Officer/Principal | - |
Philip Morris International Management SA
 Philip Morris International Management SA TobaccoConsumer Non-Durables Manufactures cigarettes and tobacco products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Philip Morris International Management SA
Philip Morris International Management SA TobaccoConsumer Non-Durables Manufactures cigarettes and tobacco products | Consumer Non-Durables |
Swissmedic
Swissmedic Miscellaneous Commercial ServicesCommercial Services Operates as national authorization for drugs and medical devices, which ensures safe and effective medical products form human and animal health | Commercial Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
